A Human Touch: Real-World Patient Data in
Regulatory Submissions and Beyond
14 March 2019 – 15.00 GMT, 16.00 CEST, 11.00 EDT
PrimeVigilance experts Dr Michael Forstner
and Maartje Smulders will be speaking on this topic.
PrimeVigilance, an Ergomed Group company,
employs over 500 highly qualified
professionals and offers competitive,
right-shoring solutions around the globe.
Providing regulatory services and clinical
development consultancy throughout the entire
life cycle of medical products with an international
team of qualified regulatory experts.
PrimeVigilance have become WORLDWIDE NUMBER ONE
in QPPV services with 25 EU QPPV assignments, as well as
25 Deputy EU QPPVs, and our local QPPV/NPRP network
covering over 60 countries.
PrimeVigilance covers the entire product life cycle, assisting clients with the effective management of their drug safety information, and offering expert consulting services from former regulators and opinion leaders.
Offering optimal approaches to life cycle benefit-risk management by providing systematic risk minimisation and faster insights into the safety and effectiveness of drugs.
PrimeVigilance is a quality resource for concise, timely and accurate communication with highly trained, industry experienced healthcare professionals providing Medical Information
In partnership with our clients, PrimeVigilance is committed to improving patient health.
Our success begins with our people. Build your career in one of the most rewarding fields in the world.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)